Women's Health Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Collaborations
University of Kentucky, biomarker research firm partner to fight ovarian cancer
September 22nd, 2005
Ciphergen Biosystems, Inc., (CIPH) announced the signing of a research and collaboration agreement with the University of Kentucky. The collaboration gives Ciphergen exclusive rights to license discoveries made during the agreement and is part of the University's ongoing research in ovarian cancer. "This agreement allows us to expand our current research in oncology by working with Doctor van Nagell and his colleagues," said Gail Page, president and chief operating officer of Ciphergen. "The University of Kentucky is a major referral center for the treatment of gynecologic malignancies. We are very pleased to be collaborating in our mutual goal to...
Source: Women's Health Weekly (2005-09-22)
|
